Tifan Sun Selected Research

Intestinal Diseases (Diseases, Intestinal)

1/2021

Oroxylin A maintains the colonic mucus barrier to reduce disease susceptibility by reconstituting a dietary fiber-deprived gut microbiota.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tifan Sun Research Topics

Disease

2	Neoplasms (Cancer) 05/2024 - 01/2021
1	Lung Neoplasms (Lung Cancer) 05/2024
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2024
1	Inflammation (Inflammations) 01/2021
1	Intestinal Diseases (Diseases, Intestinal) 01/2021
1	Multiple Myeloma 01/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021
1	Carcinogenesis 01/2021
1	Colitis-Associated Neoplasms 01/2021
1	Colitis 01/2021
1	Disease Susceptibility (Diathesis) 01/2021

Drug/Important Bio-Agent (IBA)

1	Oxidoreductases (Dehydrogenase)IBA 05/2024
1	Proteins (Proteins, Gene)FDA Link 05/2024
1	ThioredoxinsIBA 05/2024
1	Auranofin (Ridaura)FDA Link 05/2024
1	Thioredoxin Reductase 1IBA 05/2024
1	FlavonoidsIBA 01/2021
1	MucinsIBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	LT-171-861IBA 01/2021
1	5,7- dihydroxy- 6- methoxy- 2- phenylchromen- 4- oneIBA 01/2021
1	olaparibIBA 01/2021
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021
1	Dietary Fiber FDA Link 01/2021